Constipation Treatment Market Share, Size, and Trends by 2031
Constipation Treatment Market: Strategic Insights
Constipation Treatment Market
-
CAGR (2023 - 2031)6.0% -
Market Size 2023
US$ 9.93 billion -
Market Size 2031
US$ 17.69 billion
Market Dynamics
GROWTH DRIVERS
- Increasing Product Launches and Approvals
- Increasing prevelance of constipation
FUTURE TRENDS
- Increasing demnad for the treatment of Opioid-Induced Constipation
OPPORTUNITIES
- Drug Developments for Constipation
Key Players
- AbbVie s Inc
- Takeda Pharmaceutical Company Limited
- Bausch Health Companies Inc
- Bayer AG
- Mallinckrodt Plc
- Sanofi
- Albireo Pharma Inc
- AstraZeneca
- Ironwood Pharmaceuticals Inc
- Salix Pharmaceuticals Inc
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Therapeutic
- laxatives
- chloride channel activators
- peripherally acting MU-opioid receptor antagonists
- GC-C agonists
- 5-HT4 receptor agonists
Disease
- chronic idiopathic constipation
- irritable bowel syndrome with constipation
- opioid-induced constipation
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies